FDA has cleared Spectranetics’ new line of devices designed to treat clogged leg arteries. The Turbo elite products will be launched in limited release during the fourth quarter, and fully released in early 2007.
The devices are used in conjunction with the company’s excimer laser system, which helps open clogged or obstructed arteries. Spectranetics, Colorado Springs, CO, is a manufacturers of lasers used to treat heart conditions.
March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...
March 08, 2023 
March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...
March 05, 2023 
December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease ...
December 29, 2022 
November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral ...
November 15, 2022 
June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below ...
June 13, 2022 
May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...
May 20, 2022 
May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...
May 19, 2022 
March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and ...
March 22, 2022 
February 21, 2022 
February 15, 2022